Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution?
- PMID: 37587592
- DOI: 10.1016/j.jcin.2023.06.033
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution?
Keywords: P2Y(12) inhibitor; acute coronary syndrome; antiplatelet therapy; aspirin; colchicin.
Conflict of interest statement
Funding Support and Author Disclosures Dr Costa has served on an advisory board for AstraZeneca; and has received speaker fees from Chiesi Farmaceutici. Dr Micari has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study.JACC Cardiovasc Interv. 2023 Aug 14;16(15):1845-1855. doi: 10.1016/j.jcin.2023.05.035. JACC Cardiovasc Interv. 2023. PMID: 37587591 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources